Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Nov 12;12:79–86. doi: 10.2142/biophysico.12.0_79

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2015 © The Biophysical Society of Japan

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Urinary adiponectin levels measured by our ultrasensitive ELISA for healthy subjects and DM patients. (A) The urinary adiponectin concentrations in DM patients (DM, N=3) were higher (P<0.05) than those in healthy subjects (ND, N=6). DM-N, a DM patient with nephropathy; M, male; F, female. (B) The urinary creatinine concentrations in DM patients (N=3) were lower (P<0.05) than those in healthy subjects (N=6). (C) The urinary adiponectin levels, which were the values of adiponectin concentrations corrected by creatinine concentrations, were 0.73±0.50 (ng/mg creatinine) for heathy subjects (N=6) versus 12.02±3.85 ng/mg creatinine for DM patients (N=3). That is, the urinary adiponectin levels were higher in DM patients than in healthy subjects, and there seemed to be a threshold adiponectin level at around 4 ng/mg creatinine between healthy subjects and DM patients. The worse the progression of DM, the higher the urinary adiponectin level became.